Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.

Izuma NakayamaKeisho ChinTomohiro MatsushimaDaisuke TakahariMariko OguraEiji ShinozakiMitsukuni SuenagaMasato OzakaTakeru WakatsukiTakashi IchimuraOsumi HirokiKensei Yamaguchi

Published in: International journal of clinical oncology (2017)

Adding cisplatin to long-term S-1 monotherapy did not significantly improve the outcome of CY+ advanced gastric cancer patients.

Keyphrases

combination therapy
open label
high grade
neoadjuvant chemotherapy
cross sectional
squamous cell carcinoma
radiation therapy
lymph node
locally advanced